Volume 8, Issue 3 (7-2022)                   RABMS 2022, 8(3): 169-174 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sengar S, Ohary R, Kushwanshi A, David J. Analysis of 100 cervical pap smears for screening of cervical cancer at a tertiary care teaching hospital. RABMS 2022; 8 (3) :169-174
URL: http://ijrabms.umsu.ac.ir/article-1-196-en.html
Associate Professor, Shrimant Rajmata Vijayaraje Scindia Medical College, Shivpuri, Madhya Pradesh, India , raman.ohary4@gmail.com
Abstract:   (346 Views)
Background & Aims:  Cervical cancer is the fourth most common cancer among women worldwide. Pap smear testing can detect cervix precursor lesions early and reduce the morbidities and mortalities associated with cervical cancer by its early detection. The aim of this study was to analyze 100 Papanicolaou smears (PAP smears) taken from women presenting various gynecological indications as a screening method to rule out cervical cancer.
Materials & Methods:  PAP smear samples were collected using Ayres spatula devices from 100 women between the ages of 25 and 70 who reffered to the Gynecological Outpatient Department with different gynecological complaints. Smear reports were reported as per the 2013 Bethesda system.
Results:  The common presenting complaints of women in our study were abnormal vaginal discharge (p/v 55%), followed by pruritities valve (9%), intermenstrual bleeding (8%), and postcoital bleeding (2%). On speculum examination of the cervixes, 30% had chronic cervicitis. Cervix bleeds on touch in only 4% of the women. Abnormal vaginal discharge is seen in 60% of women. 36% of smears were inflammatory, 5% had low-grade squamous intraepithelial lesions, and 2% had high-grade squamous intraepithelial lesions. ASCUS and ASC-H were reported in 3% and 1% of the smears, respectively.
Conclusion:  PAP smear is a very easy and economical screening method to detect premalignant and malignant lesions of the cervix, which helps in proper treatment.
Full-Text [PDF 273 kb]   (131 Downloads)    
Type of Study: orginal article | Subject: General

References
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021 May;71(3):209-49. [DOI:10.3322/caac.21660] [PMID]
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: source, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):359-86. [DOI:10.1002/ijc.29210] [PMID]
3. Bruni L, Barrionuevo-Rosas L, Albero G, Aldea M, Serrano B, Valencia S, et al. ICO information Centre on HPV and Cancer (HPV information centre) human papillomavirus and related diseases reports [cited Mar 20 2015]. Available from: http://www.hpvcentre.net/statistics/reports/XWX.pdf. [URL]
4. Shanmugham D, Vijay A, Rangaswamy T. Colposcopic evaluation of patient with persistent inflammatory pap smear. Sch J App Med Sci 2014;2:1010-3. [URL]
5. Umarani MK, Gayathri MN, Kumar RM. Study of cervical cytology in Papanicolaou (Pap) smears in a tirtiary care hospital. Indian J Pathol Oncol. 2016;3;11:679-83. [DOI:10.5958/2394-6792.2016.00126.5]
6. Bal MS, Goyal R, Suri AK, Mohi MK. Detection of abnormal cervical cytology in Papanicolaou smears. J Cytol 2012;29(1):45-7. [DOI:10.4103/0970-9371.93222] [PMID] [PMCID]
7. Ansari M, Mehdi G, Arif SH, Ansari H, Khan T. Smear patterns and spectrum of premalignant lesions in postmenopausal Indian women: A hospital based study. Diagn Cytopathpathol 2012;40:976-83. [DOI:10.1002/dc.21708] [PMID]
8. Thomas A, Corrara MMA, Kumar KR. The Bathesda system recommendation in reporting benign endometrial cells in cervical smears from postmenopausal women published by American Cancer Society. Indian J Pathol Microbiol 2002;25:134-8.
9. Ngoma T. World Health Organization cancer priorities in developing countries. Ann Oncol 2006;17:9-14. [DOI:10.1093/annonc/mdl982] [PMID]
10. Vaghela BK, Vaghela VK, Santwani PM. Analysis of abnormal cervical cytology in papanicolaou smears at tertiary care center-A retrospective study. Int J of Biomed Adv Res 2014;5:47-9. [DOI:10.7439/ijbar.v5i1.551]
11. Aswathy S, Quereshi MA, Kurian B, Leelamoni K. Cervical cancer screening; Current knowledge and practice among women in a rural population of Kerala, India. Indian J Med Res 2012;136(2):205-10. [PMID] [PMCID]
12. Davey DD. Cervical cytology classification and the Bethesda System. Cancer J 2003;9(5):327-34. [DOI:10.1097/00130404-200309000-00002] [PMID]
13. Nayir T, Okyay AR, Nizlican E, Yesilyurt H, Akbaba M, Ilhan B, et al. Cervicalcancer screening in an early diagnosis and screening centre in Mersin, Turkey. Asian Pac J Cancer Prev 2015;16:690-12. [DOI:10.7314/APJCP.2015.16.16.6909] [PMID]
14. Sreedevi A, Javed R, Dinesh A. Epidemiology of cervical cancer with special focus on India. Int J Womens Health 2015;7:405-14. [DOI:10.2147/IJWH.S50001] [PMID] [PMCID]
15. Sunita A, Bamanikar SA, Baravkar DS. chandanwale SS, Dapkekar P. Study of cervical pap smears in a tertiary hospital. Int J Sci Res 2016;5(5):2071-4. [DOI:10.21275/v5i5.NOV163871]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Journal of Research in Applied and Basic Medical Sciences

Designed & Developed by : Yektaweb